PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
- Authors:
- USP affiliated authors: SAGGIORO, FABIANO PINTO - SVOI ; CHESCA, DEISE LUCIA - FMRP ; REIS, RODOLFO BORGES DOS - FMRP ; SQUIRE, JEREMY ANDREW - FMRP ; VIDOTTO, THIAGO - FMRP ; ALBUQUERQUE, CLARISSA GONDIM PICANÇO DE - FMRP
- Unidades: SVOI; FMRP
- DOI: 10.1002/pros.23808
- Subjects: PRÓSTATA; NEOPLASIAS; SISTEMA IMUNE; REGULAÇÃO GÊNICA
- Keywords: IDO1; Immune checkpoint; Prostate cancer; PTEN; T regulatory cell; Tumor microenvironment
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Prostate
- ISSN: 0270-4137
- Volume/Número/Paginação/Ano: v. 79, n. 9, p. 969-979, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 18 fev. 2026. -
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808 -
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1002/pros.23808 -
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1002/pros.23808 - PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features
- Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
- PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer
- Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
- Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer
- Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment
- Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics
- The role of somatic mutations on the immune response of the tumor microenvironment in prostate cancer
Informações sobre o DOI: 10.1002/pros.23808 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002979769.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
